Topics

Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics appoints a new Chief Medical Officer

06:05 EDT 25 Mar 2019 | FinanzNachrichten

STOCKHOLM, March 25, 2019. Karolinska Development's portfolio company Aprea Therapeutics announces today that Dr. Eyal C. Attar has been appointed to a position as Senior Vice President and Chief ...

Original Article: Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics appoints a new Chief Medical Officer

NEXT ARTICLE

More From BioPortfolio on "Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics appoints a new Chief Medical Officer"

Quick Search